NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Hunan Jiudian Pharmaceutical Co. Ltd (SHE: 300705)
300705 Technical Analysis
5
As on 2nd Jan 2025 300705 STOCK Price closed @ 17.15 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 29.38 & Strong Sell for SHORT-TERM with Stoploss of 22.59 we also expect STOCK to react on Following IMPORTANT LEVELS. |
300705STOCK Price
Open | 17.95 | Change | Price | % |
High | 18.09 | 1 Day | -0.80 | -4.46 |
Low | 16.95 | 1 Week | -5.69 | -24.91 |
Close | 17.15 | 1 Month | -7.63 | -30.79 |
Volume | 32726645 | 1 Year | -9.00 | -34.42 |
52 Week High 38.90 | 52 Week Low 18.06 |
SHE China Most Active Stocks
300059 | 23.99 | -7.09% |
000564 | 3.53 | 2.32% |
000725 | 4.24 | -3.42% |
002131 | 3.11 | 0.65% |
000100 | 4.95 | -1.59% |
002717 | 3.37 | 4.33% |
002640 | 4.22 | 9.90% |
002269 | 2.24 | 9.80% |
002607 | 3.34 | -1.76% |
000063 | 37.93 | -6.11% |
SHE China Top Gainers Stocks
SHE China Top Losers Stocks
300705 Daily Charts |
300705 Intraday Charts |
Whats New @ Bazaartrend |
300705 Free Analysis |
|
300705 Important Levels Intraday
RESISTANCE | 19.35 |
RESISTANCE | 18.64 |
RESISTANCE | 18.21 |
RESISTANCE | 17.77 |
SUPPORT | 16.53 |
SUPPORT | 16.09 |
SUPPORT | 15.66 |
SUPPORT | 14.95 |
300705 Forecast January 2025
4th UP Forecast | 31.43 |
3rd UP Forecast | 26.85 |
2nd UP Forecast | 24.02 |
1st UP Forecast | 21.19 |
1st DOWN Forecast | 13.11 |
2nd DOWN Forecast | 10.28 |
3rd DOWN Forecast | 7.45 |
4th DOWN Forecast | 2.87 |
300705 Weekly Forecast
4th UP Forecast | 20.04 |
3rd UP Forecast | 19.11 |
2nd UP Forecast | 18.54 |
1st UP Forecast | 17.97 |
1st DOWN Forecast | 16.33 |
2nd DOWN Forecast | 15.76 |
3rd DOWN Forecast | 15.19 |
4th DOWN Forecast | 14.26 |
300705 Forecast2025
4th UP Forecast | 60.99 |
3rd UP Forecast | 46.93 |
2nd UP Forecast | 38.24 |
1st UP Forecast | 29.55 |
1st DOWN Forecast | 4.75 |
2nd DOWN Forecast | -3.94 |
3rd DOWN Forecast | -12.63 |
4th DOWN Forecast | -26.69 |
Hunan Jiudian Pharmaceutical Co. Ltd ( SHE China Symbol : 300705 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
300705 Other Details
Segment | EQ | |
Market Capital | 5350703616.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
300705 Address
300705 Latest News
300705 Business Profile
Hunan Jiudian Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. The company offers antiallergic, anti-infective, and anti-inflammatory drugs; analgosies and gynecological medication products; digestive system products; chemical and Chinese patent medicines; medical instruments; APIs; and other products. It also provides outsourcing services for tablets, capsules, granules, oral solutions, syrups, etc. Hunan Jiudian Pharmaceutical Co., Ltd. is based in Changsha, China. Address: Building A1, Shibuya Science and Technology Industrial Park, Changsha, China, 410329
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service